Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures
| Autor: | Audrey Derveloy, Salomon-Yves Cohen, Alexandros Sagkriotis, Claudia Leteneux, Sascha Bayer, Sylvia Nghiem-Buffet, Guido Becker, Eric H. Souied |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Vascular Endothelial Growth Factor A
medicine.medical_specialty Drug compounding business.industry Drug Compounding Syringes Ranibizumab Prefilled Syringe Angiogenesis Inhibitors General Medicine Vial Surgery Ophthalmology Cross-Sectional Studies Multicenter study Ranibizumab Time and Motion Studies Intravitreal Injections Humans Medicine business Prefilled Syringe Preparation procedures Syringe medicine.drug |
| Zdroj: | European Journal of Ophthalmology. 25:529-534 |
| ISSN: | 1724-6016 1120-6721 |
| DOI: | 10.5301/ejo.5000629 |
| Popis: | Purpose A recently developed ranibizumab prefilled syringe (PFS) eliminates several preparatory steps versus the standard vial-based method, and is expected to reduce syringe preparation time (SPT) and enhance procedural simplicity for intravitreal injections. Methods Syringe preparation times for the ranibizumab PFS and vial were recorded during standard treatment sessions at 2 centers, without randomization. The duration of each step in preparing the syringe was recorded. At each center, total SPT (mean total duration of all syringe preparation steps) for each method was compared using a 2-tailed t test. Results In total, 97 SPTs were analyzed across both centers. Center 1 SPTs were 46 seconds (PFS) versus 75 seconds (vial; difference, 29 seconds; pConclusions Syringe preparation times for ranibizumab intravitreal injections are significantly shorter with the PFS than with the vial. The time saved by using the PFS may benefit physicians and nurses, and the simplicity of the injection preparation process with the PFS is advantageous. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|